Selected research
Industry Research
Chronic Disease Treatment Industry Research Report 2026
Market perspective
The global Chronic Disease Treatment market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Chronic Disease Treatment market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Chronic Disease Treatment market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Chronic Disease Treatment market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Chronic Disease Treatment include PrecisionLife, Novo Nordisk, Becton Dickinson, Apollo TeleHealth, Sidekick Health, AstraZeneca, Biofourmis, S3 Connected Health and MindMaze, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Chronic Disease Treatment market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Chronic Disease Treatment.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Chronic Disease Treatment Market by Company
PrecisionLife
Novo Nordisk
Becton Dickinson
Apollo TeleHealth
Sidekick Health
AstraZeneca
Biofourmis
S3 Connected Health
MindMaze
CSL Vifor
Aetna Better Health
Vancouver Coastal Health
Diathrive Health
Chronic Disease Treatment Segment by Type
Medical Treatement
Physiotherapy
Surgical Treatment
Others
Chronic Disease Treatment Segment by Application
Chronic Respiratory Disease
Chronic Cardiovascular Disease
Chronic Digestive Diseases
Chronic Urinary Tract Disease
Endocrine System Diseases
Others
Chronic Disease Treatment Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Chronic Disease Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Chronic Disease Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Chronic Disease Treatment.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Chronic Disease Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Medical Treatement
- Physiotherapy
- Surgical Treatment
- Others
Applications
- Chronic Respiratory Disease
- Chronic Cardiovascular Disease
- Chronic Digestive Diseases
- Chronic Urinary Tract Disease
- Endocrine System Diseases
- Others
Companies covered
- PrecisionLife
- Novo Nordisk
- Becton Dickinson
- Apollo TeleHealth
- Sidekick Health
- AstraZeneca
- Biofourmis
- S3 Connected Health
- MindMaze
- CSL Vifor
- Aetna Better Health
- Vancouver Coastal Health
- Diathrive Health
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Chronic Disease Treatment by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Medical Treatement
- 2.2.3 Physiotherapy
- 2.2.4 Surgical Treatment
- 2.2.5 Others
- 2.3 Chronic Disease Treatment by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Chronic Respiratory Disease
- 2.3.3 Chronic Cardiovascular Disease
- 2.3.4 Chronic Digestive Diseases
- 2.3.5 Chronic Urinary Tract Disease
- 2.3.6 Endocrine System Diseases
- 2.3.7 Others
- 2.4 Assumptions and Limitations
3 Chronic Disease Treatment Breakdown Data by Type
- 3.1 Global Chronic Disease Treatment Historic Market Size by Type (2021-2026)
- 3.2 Global Chronic Disease Treatment Forecasted Market Size by Type (2027-2032)
4 Chronic Disease Treatment Breakdown Data by Application
- 4.1 Global Chronic Disease Treatment Historic Market Size by Application (2021-2026)
- 4.2 Global Chronic Disease Treatment Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Chronic Disease Treatment Market Perspective (2021-2032)
- 5.2 Global Chronic Disease Treatment Growth Trends by Region
- 5.2.1 Global Chronic Disease Treatment Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Chronic Disease Treatment Historic Market Size by Region (2021-2026)
- 5.2.3 Chronic Disease Treatment Forecasted Market Size by Region (2027-2032)
- 5.3 Chronic Disease Treatment Market Dynamics
- 5.3.1 Chronic Disease Treatment Industry Trends
- 5.3.2 Chronic Disease Treatment Market Drivers
- 5.3.3 Chronic Disease Treatment Market Challenges
- 5.3.4 Chronic Disease Treatment Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Chronic Disease Treatment Players by Revenue
- 6.1.1 Global Top Chronic Disease Treatment Players by Revenue (2021-2026)
- 6.1.2 Global Chronic Disease Treatment Revenue Market Share by Players (2021-2026)
- 6.2 Global Chronic Disease Treatment Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Chronic Disease Treatment Head Office and Area Served
- 6.4 Global Chronic Disease Treatment Players, Product Type & Application
- 6.5 Global Chronic Disease Treatment Manufacturers Established Date
- 6.6 Global Chronic Disease Treatment Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Chronic Disease Treatment Market Size (2021-2032)
- 7.2 North America Chronic Disease Treatment Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Chronic Disease Treatment Market Size by Country (2021-2026)
- 7.4 North America Chronic Disease Treatment Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Chronic Disease Treatment Market Size (2021-2032)
- 8.2 Europe Chronic Disease Treatment Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Chronic Disease Treatment Market Size by Country (2021-2026)
- 8.4 Europe Chronic Disease Treatment Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Chronic Disease Treatment Market Size (2021-2032)
- 9.2 Asia-Pacific Chronic Disease Treatment Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Chronic Disease Treatment Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Chronic Disease Treatment Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Chronic Disease Treatment Market Size (2021-2032)
- 10.2 South America Chronic Disease Treatment Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Chronic Disease Treatment Market Size by Country (2021-2026)
- 10.4 South America Chronic Disease Treatment Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Chronic Disease Treatment Market Size (2021-2032)
- 11.2 Middle East & Africa Chronic Disease Treatment Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Chronic Disease Treatment Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Chronic Disease Treatment Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 PrecisionLife
- 12.1.1 PrecisionLife Company Information
- 12.1.2 PrecisionLife Business Overview
- 12.1.3 PrecisionLife Revenue in Chronic Disease Treatment Business (2021-2026)
- 12.1.4 PrecisionLife Chronic Disease Treatment Product Portfolio
- 12.1.5 PrecisionLife Recent Developments
- 12.2 Novo Nordisk
- 12.2.1 Novo Nordisk Company Information
- 12.2.2 Novo Nordisk Business Overview
- 12.2.3 Novo Nordisk Revenue in Chronic Disease Treatment Business (2021-2026)
- 12.2.4 Novo Nordisk Chronic Disease Treatment Product Portfolio
- 12.2.5 Novo Nordisk Recent Developments
- 12.3 Becton Dickinson
- 12.3.1 Becton Dickinson Company Information
- 12.3.2 Becton Dickinson Business Overview
- 12.3.3 Becton Dickinson Revenue in Chronic Disease Treatment Business (2021-2026)
- 12.3.4 Becton Dickinson Chronic Disease Treatment Product Portfolio
- 12.3.5 Becton Dickinson Recent Developments
- 12.4 Apollo TeleHealth
- 12.4.1 Apollo TeleHealth Company Information
- 12.4.2 Apollo TeleHealth Business Overview
- 12.4.3 Apollo TeleHealth Revenue in Chronic Disease Treatment Business (2021-2026)
- 12.4.4 Apollo TeleHealth Chronic Disease Treatment Product Portfolio
- 12.4.5 Apollo TeleHealth Recent Developments
- 12.5 Sidekick Health
- 12.5.1 Sidekick Health Company Information
- 12.5.2 Sidekick Health Business Overview
- 12.5.3 Sidekick Health Revenue in Chronic Disease Treatment Business (2021-2026)
- 12.5.4 Sidekick Health Chronic Disease Treatment Product Portfolio
- 12.5.5 Sidekick Health Recent Developments
- 12.6 AstraZeneca
- 12.6.1 AstraZeneca Company Information
- 12.6.2 AstraZeneca Business Overview
- 12.6.3 AstraZeneca Revenue in Chronic Disease Treatment Business (2021-2026)
- 12.6.4 AstraZeneca Chronic Disease Treatment Product Portfolio
- 12.6.5 AstraZeneca Recent Developments
- 12.7 Biofourmis
- 12.7.1 Biofourmis Company Information
- 12.7.2 Biofourmis Business Overview
- 12.7.3 Biofourmis Revenue in Chronic Disease Treatment Business (2021-2026)
- 12.7.4 Biofourmis Chronic Disease Treatment Product Portfolio
- 12.7.5 Biofourmis Recent Developments
- 12.8 S3 Connected Health
- 12.8.1 S3 Connected Health Company Information
- 12.8.2 S3 Connected Health Business Overview
- 12.8.3 S3 Connected Health Revenue in Chronic Disease Treatment Business (2021-2026)
- 12.8.4 S3 Connected Health Chronic Disease Treatment Product Portfolio
- 12.8.5 S3 Connected Health Recent Developments
- 12.9 MindMaze
- 12.9.1 MindMaze Company Information
- 12.9.2 MindMaze Business Overview
- 12.9.3 MindMaze Revenue in Chronic Disease Treatment Business (2021-2026)
- 12.9.4 MindMaze Chronic Disease Treatment Product Portfolio
- 12.9.5 MindMaze Recent Developments
- 12.10 CSL Vifor
- 12.10.1 CSL Vifor Company Information
- 12.10.2 CSL Vifor Business Overview
- 12.10.3 CSL Vifor Revenue in Chronic Disease Treatment Business (2021-2026)
- 12.10.4 CSL Vifor Chronic Disease Treatment Product Portfolio
- 12.10.5 CSL Vifor Recent Developments
- 12.11 Aetna Better Health
- 12.11.1 Aetna Better Health Company Information
- 12.11.2 Aetna Better Health Business Overview
- 12.11.3 Aetna Better Health Revenue in Chronic Disease Treatment Business (2021-2026)
- 12.11.4 Aetna Better Health Chronic Disease Treatment Product Portfolio
- 12.11.5 Aetna Better Health Recent Developments
- 12.12 Vancouver Coastal Health
- 12.12.1 Vancouver Coastal Health Company Information
- 12.12.2 Vancouver Coastal Health Business Overview
- 12.12.3 Vancouver Coastal Health Revenue in Chronic Disease Treatment Business (2021-2026)
- 12.12.4 Vancouver Coastal Health Chronic Disease Treatment Product Portfolio
- 12.12.5 Vancouver Coastal Health Recent Developments
- 12.13 Diathrive Health
- 12.13.1 Diathrive Health Company Information
- 12.13.2 Diathrive Health Business Overview
- 12.13.3 Diathrive Health Revenue in Chronic Disease Treatment Business (2021-2026)
- 12.13.4 Diathrive Health Chronic Disease Treatment Product Portfolio
- 12.13.5 Diathrive Health Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst